| Old Articles: <Older 1381-1390 Newer> |
|---|
 |
The Motley Fool
March 23, 2004
W.D. Crotty |
Down on Drug News? An FDA advisory on labeling antidepressants shouldn't depress drug stocks.   |
The Motley Fool
March 23, 2004
Tim Beyers |
McCormick Maxed Out? The spice maker delivers hot results, but its valuation might cause indigestion. |
The Motley Fool
March 23, 2004
Dave Marino-Nachison |
Winking at Charming Shoppes Improved profit margins have the plus-size women's apparel retailer back in style. |
The Motley Fool
March 23, 2004
Seth Jayson |
palmOne's Partial Report Pleases Revenue and non-GAAP earnings increase, but things are less rosy between the lines. |
The Motley Fool
March 23, 2004
David Forrest |
Play Detective With Your Stocks Be ready to ask the important questions. Whenever one of your companies reports new fundamental information, it's time to get out your magnifying glass and prepare to ask tough questions. The answers will make the difference between your success or failure as an investor. |
The Motley Fool
March 23, 2004
Glen Trematore |
Stryker's a Warrior Need a new hip or a new addition to your portfolio? Consider Stryker. |
The Motley Fool
March 23, 2004
Dave Marino-Nachison |
Jones Apparel Gets Hostile Jones Apparel was playing nice. Now, it's going on the open market to buy Maxwell Shoe. |
The Motley Fool
March 23, 2004
Seth Jayson |
Family Dollar Holds Its Own Revenue increases belie modest comps. Family Dollar needs to attract more families' dollars. |
The Motley Fool
March 23, 2004
Rick Aristotle Munarriz |
Limited's Unlimited Upside The popular mallrat is putting the "special" back in specialty retailing. |
BusinessWeek
March 29, 2004
David Welch |
Auto Megadealers: Running Out Of Gas? They're debt-heavy after a buying spree, and their margins are suffering. Now investors are starting to gear down |
| <Older 1381-1390 Newer> Return to current articles. |
